Drug Diversion Monitoring Software Product Ranking Comparison

Drug diversion monitoring continues to be a top area of interest for pharmacy departments across the US as they seek to understand which products can effectively identify non-compliant behavior and otherwise unknown diverters. This report—KLAS’ first to analyze the performance of several vendors in this area—looks at which vendors are consistently delivering guidance, analytics, and insights that help organizations identify and prevent drug diversion. In addition, this report examines the outcomes provider organizations are achieving and how well vendors follow through on commitments.

Recent Insights

Key Findings:

Kit Check Customers Say High Ease of Use Facilitates Outcomes
Protenus’ Proactive Diversion Insights Guide Customer Investigations
Despite Mixed Experience with BD’s Guidance & Support, Customers Feel Optimistic about the Future
Customer Satisfaction with Imprivata (Limited Data) Has Significantly Declined

Performance Data

Overall Score by Product

Products Appearing in Decisions

Overall Score by Question Topic

Provider Facility Size by Product

Provider Facility Type by Product

Though the COVID-19 pandemic has been a major focus for the past few years, drug diversion is still a pressing problem for healthcare organizations. This can potentially involve lawsuits, federal fine

We are all aware of the fact that healthcare lags behind other industries. Barriers such as heavy regulations and intense scrutiny weigh down technological advancements. And as KLAS’ Medication Invent

Decision Insights

Drug Diversion Monitoring 2021

04 January 22 | Jackson Tate and Jennifer Hickenlooper

In the last 12 months, KLAS has interviewed 41 healthcare organizations that have recently purchased a drug diversion monitoring solution or are in the process of doing so. This represents a sharp increase in market activity. Several factors are fueling the growth, including greater awareness of the opioid crisis as well as a greater need during the COVID-19 pandemic for visibility and automation when it comes to managing medication inventories. Additionally, organizations are considering several newer technology options purported to offer more intuitive workflows and more complete investigational tools. This report examines recent and upcoming drug diversion monitoring purchase decisions to determine which vendors are generating the highest interest.

Drug Diversion Monitoring

Latest Category Report